Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GDRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGDRXGoodRx$4.76-5.8%$4.35$3.68▼$9.26$1.68B1.241.43 million shs2.82 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGDRXGoodRx0.00%-2.88%+18.68%+15.51%-39.07%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGDRXGoodRx3.0406 of 5 stars3.32.00.00.01.42.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGDRXGoodRx 2.64Moderate Buy$6.5537.54% UpsideCurrent Analyst Ratings BreakdownLatest GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025GDRXGoodRxUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.255/9/2025GDRXGoodRxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.004/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/10/2025GDRXGoodRxTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.50 ➝ $5.50(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGDRXGoodRx$792.32M2.15$0.32 per share14.81$1.89 per share2.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGDRXGoodRx$16.39M$0.0859.4926.442.093.57%7.85%3.91%8/6/2025 (Estimated)Latest GDRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025GDRXGoodRx$0.04$0.09+$0.05$0.03$202.25 million$202.97 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGDRXGoodRxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGDRXGoodRx0.745.235.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGDRXGoodRx63.77%Insider OwnershipCompanyInsider OwnershipGDRXGoodRx4.53%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGDRXGoodRx950357.17 million340.99 millionOptionableGDRX HeadlinesRecent News About These CompaniesEquity Vii L.P. Spectrum Sells 10,677 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) StockJuly 4 at 8:31 AM | insidertrades.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Equity Vii L.P. Spectrum Sells 10,677 SharesJuly 3 at 9:11 PM | marketbeat.comGoodRx (NASDAQ:GDRX) Trading Down 3% - Time to Sell?July 3 at 1:13 PM | marketbeat.comWhile institutions own 22% of GoodRx Holdings, Inc. (NASDAQ:GDRX), individual investors are its largest shareholders with 48% ownershipJuly 3 at 3:36 AM | finance.yahoo.comGoodRx (GDRX) Unveils Lifecycle to Enhance Engineering MethodologiesJune 27, 2025 | msn.comCWA Asset Management Group LLC Buys Shares of 66,275 GoodRx Holdings, Inc. (NASDAQ:GDRX)June 22, 2025 | marketbeat.comGoodRx (GDRX) Launches a New Subscription Service for Erectile Dysfunction TreatmentJune 15, 2025 | finance.yahoo.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Recommendation of "Moderate Buy" by AnalystsJune 15, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX) and Insmed (INSM)June 13, 2025 | theglobeandmail.comGDRX Q1 Earnings Call: Management Focuses on Pharmacy Partnerships and Marketplace EvolutionJune 12, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 61,924 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)June 12, 2025 | marketbeat.comGoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?June 10, 2025 | msn.comGoodRx (NASDAQ:GDRX) Shares Gap Up - Here's WhyJune 10, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Bank of America Corp DEJune 10, 2025 | marketbeat.comInsider Selling: GoodRx Holdings, Inc. (NASDAQ:GDRX) Major Shareholder Sells 10,677 Shares of StockJune 9, 2025 | marketbeat.comGoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus PricingJune 9, 2025 | businesswire.comGoodRx: Stabilizing Revenue Amid Healthy Profit GainsJune 6, 2025 | seekingalpha.comGoodRx (NASDAQ:GDRX) Shares Up 5.9% - Still a Buy?June 5, 2025 | marketbeat.comGoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer ProductivityJune 5, 2025 | businesswire.comJim Cramer Holds Back on GoodRx (GDRX)June 5, 2025 | insidermonkey.comGoodRx to Launch Direct Contracting for Independent Community PharmaciesMay 22, 2025 | standard-journal.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGDRX Company DescriptionsGoodRx NASDAQ:GDRX$4.76 -0.29 (-5.76%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$4.75 -0.01 (-0.19%) As of 07/3/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
